PureTech Health (PRTC) Other Non-Current Assets (2019 - 2025)

PureTech Health (PRTC) reported Other Non-Current Assets of -$12.7 million for Q4 2025, down 150.84% year-over-year from $25.0 million in Q4 2024, and down 2770.95% quarter-over-quarter from $475000.0 in Q2 2025.

PureTech Health (PRTC) Other Non-Current Assets (2019 - 2025) Analysis & Trends

PureTech Health (PRTC) has 7 years of Other Non-Current Assets data on file, last reported at -$12.7 million in Q4 2025.

  • Other Non-Current Assets for Q4 2025 came in at -$12.7 million, down 150.84% year-over-year; the trailing twelve-month figure through Dec 2025 was -$12.7 million (down 150.84% YoY), and the FY2025 annual result was -$12.7 million, down 150.84% from the prior year.
  • Other Non-Current Assets eased to -$12.7 million in Q4 2025 per PRTC's latest filing, from $475000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $64.6 million in Q4 2022 and troughed at -$12.7 million in Q4 2025.
  • A 5-year average of $22.0 million and a median of $25.0 million in 2024 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 37.31% in 2022, then sank 150.84% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $47.0 million in 2021, then jumped by 37.31% to $64.6 million in 2022, then tumbled by 55.19% to $28.9 million in 2023, then retreated by 13.75% to $25.0 million in 2024, then slumped by 150.84% to -$12.7 million in 2025.
  • Business Quant data shows PRTC's Other Non-Current Assets at -$12.7 million in Q4 2025, $475000.0 in Q2 2025, and $25.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 PureTech Health 86.36 Mn -190.94 Mn - -12.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.69 Mn
Jun 30, 2025 475,000.00
Dec 31, 2024 24.95 Mn
Jun 30, 2024 878,000.00
Dec 31, 2023 28.93 Mn
Dec 31, 2022 64.56 Mn
Dec 31, 2021 47.02 Mn
Dec 31, 2020 45.48 Mn
Dec 31, 2019 2.12 Mn